| pubmed-article:7536347 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7536347 | lifeskim:mentions | umls-concept:C0079459 | lld:lifeskim |
| pubmed-article:7536347 | lifeskim:mentions | umls-concept:C0280342 | lld:lifeskim |
| pubmed-article:7536347 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:7536347 | pubmed:dateCreated | 1995-5-12 | lld:pubmed |
| pubmed-article:7536347 | pubmed:abstractText | Therapy with myeloid colony-stimulating factors has been safely and effectively used in a wide variety of situations associated with neutropenia. We present a case of pseudoleukemia occurring in a patient with lymphoma and pancytopenia after 2 days of treatment with granulocyte colony-stimulating factor (G-CSF). Bone marrow aspirate and flow cytometry study results were consistent with acute myelomonocytic leukemia but were normal after G-CSF was discontinued for 4 days. As previous phase I studies of bone marrow morphology after G-CSF use have not described the extreme myeloid immaturity seen in this patient, it seems likely that the action of G-CSF was enhanced by factors associated with the patient's illness. We emphasize the clinical importance of this case in light of the widespread use of G-CSF. | lld:pubmed |
| pubmed-article:7536347 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7536347 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7536347 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:7536347 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7536347 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7536347 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7536347 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7536347 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7536347 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7536347 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7536347 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:7536347 | pubmed:issn | 0038-4348 | lld:pubmed |
| pubmed-article:7536347 | pubmed:author | pubmed-author:StrairR KRK | lld:pubmed |
| pubmed-article:7536347 | pubmed:author | pubmed-author:CooperD LDL | lld:pubmed |
| pubmed-article:7536347 | pubmed:author | pubmed-author:YenYY | lld:pubmed |
| pubmed-article:7536347 | pubmed:author | pubmed-author:FlynnS DSD | lld:pubmed |
| pubmed-article:7536347 | pubmed:author | pubmed-author:RealeM AMA | lld:pubmed |
| pubmed-article:7536347 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7536347 | pubmed:volume | 88 | lld:pubmed |
| pubmed-article:7536347 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7536347 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7536347 | pubmed:pagination | 462-4 | lld:pubmed |
| pubmed-article:7536347 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:7536347 | pubmed:meshHeading | pubmed-meshheading:7536347-... | lld:pubmed |
| pubmed-article:7536347 | pubmed:meshHeading | pubmed-meshheading:7536347-... | lld:pubmed |
| pubmed-article:7536347 | pubmed:meshHeading | pubmed-meshheading:7536347-... | lld:pubmed |
| pubmed-article:7536347 | pubmed:meshHeading | pubmed-meshheading:7536347-... | lld:pubmed |
| pubmed-article:7536347 | pubmed:meshHeading | pubmed-meshheading:7536347-... | lld:pubmed |
| pubmed-article:7536347 | pubmed:meshHeading | pubmed-meshheading:7536347-... | lld:pubmed |
| pubmed-article:7536347 | pubmed:meshHeading | pubmed-meshheading:7536347-... | lld:pubmed |
| pubmed-article:7536347 | pubmed:meshHeading | pubmed-meshheading:7536347-... | lld:pubmed |
| pubmed-article:7536347 | pubmed:meshHeading | pubmed-meshheading:7536347-... | lld:pubmed |
| pubmed-article:7536347 | pubmed:meshHeading | pubmed-meshheading:7536347-... | lld:pubmed |
| pubmed-article:7536347 | pubmed:meshHeading | pubmed-meshheading:7536347-... | lld:pubmed |
| pubmed-article:7536347 | pubmed:meshHeading | pubmed-meshheading:7536347-... | lld:pubmed |
| pubmed-article:7536347 | pubmed:meshHeading | pubmed-meshheading:7536347-... | lld:pubmed |
| pubmed-article:7536347 | pubmed:meshHeading | pubmed-meshheading:7536347-... | lld:pubmed |
| pubmed-article:7536347 | pubmed:meshHeading | pubmed-meshheading:7536347-... | lld:pubmed |
| pubmed-article:7536347 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7536347 | pubmed:articleTitle | Pseudoleukemia after granulocyte colony-stimulating factor therapy. | lld:pubmed |
| pubmed-article:7536347 | pubmed:affiliation | Department of Internal Medicine, Yale-New Haven Hospital, CT, USA. | lld:pubmed |
| pubmed-article:7536347 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7536347 | pubmed:publicationType | Case Reports | lld:pubmed |
